Increased serum vascular endothelial growth factor following major surgical injury

Journal of Nippon Medical School

Volumn 74, Issue 3, 2007, Pages 223-229

  Futami, Ryouhei ^a   Miyashita, Masao ^a   Nomura, Tsutomu ^a   Makino, Hiroshi ^a   Matsutani, Takeshi ^a   Sasajima, Koji ^a   Tajiri, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Major surgery; Platelet; Vascular endothelial growth factor; Wound healing

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CHOLECYSTECTOMY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GALLSTONE; HUMAN; LAPAROSCOPIC SURGERY; LYMPHADENECTOMY; MALE; MINIMALLY INVASIVE SURGERY; PROTEIN BLOOD LEVEL; SURGICAL INJURY;

ADULT; CHOLECYSTECTOMY, LAPAROSCOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGECTOMY; FEMALE; HUMANS; INFLAMMATION; LYMPH NODE EXCISION; MALE; MIDDLE AGED; SURGICAL PROCEDURES, OPERATIVE; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 34347329015     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.223     Document Type: Article

References (35)

1. Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870.
2. Tonnesen MG, Feng X, Clark RA: Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 5: 40-46.
3. Ferrara N: Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 2000; 55: 15-36.
4. Senger DR, Van de Water L, Brown LF, et al.: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993; 12: 303-324.
5. Haga Y, Beppu T, Doi K, et al.: Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med 1997; 25: 1994-2000.
6. Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE: Pulmonary complications after esophagectomy. Ann Thorac Surg 2002; 73: 922-926.
7. Verheul HM, Hoekman K, Luykx-de Bakker S, et al.: Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997; 3: 2187-2190.
8. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE: Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998; 94: 395-404.
9. Wynendaele W, Derua R, Hoylaerts MF, et al.: Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol 1999; 10: 965-971.
10. Salven P, Teerenhovi L, Joensuu H: A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90: 3167-3172.
11. Takemura M, Seishima M, Saito K, et al.: Evaluation of interleukin 6 (IL-6) measurement by highly sensitive chemiluminescent enzyme immunoassey. Igaku to Yakugaku 1996; 36: 1071-1076.
12. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723.
13. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA: Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452.
14. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858.
15. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC: Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131-3139.
16. Gospodarowicz D, Brown KD, Birdwell CR, Zetter BR: Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol 1978; 77: 774-788.
17. O'Reilly MS, Holmgren L, Shing Y, et al.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
18. O'Reilly MS, Boehm T, Shing Y, et al.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
19. Maheshwari RK, Srikantan V, Bhartiya D, Kleinman HK, Grant DS: Differential effects of interferon gamma and alpha on in vitro model of angiogenesis. J Cell Physiol 1991; 146: 164-169.
20. Malamitsi-Puchner A, Tziotis J, Tsonou A, Protonotariou E, Sarandakou A, Creatsas G: Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Investig 2000; 7: 309-312.
21. Nielsen HJ, Werther K, Mynster T, Brunner N: Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 1999; 39: 1078-1083.
22. Werther K, Christensen IJ, Nielsen HJ: The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. Eur J Surg 2001; 167: 287-292.
23. Bauditz J, Schachschal G, Wedel S, Lochs H: Thalidomide for treatment of severe intestinal bleeding. Gut 2004; 53: 609-612.
24. Shono T, Inamura T, Morioka T, et al.: Vascular endothelial growth factor in chronic subdural haematomas. J Clin Neurosci 2001; 8: 411-415.
25. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI: Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 2000; 6: 3147-3152.
26. Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI: Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol 2000; 17: 149-152.
27. Miyashita M, Tajiri T, Yanagi K, et al.: Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors. Hepatogastroenterology 2003; 50: 308-309.
28. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
29. Mohle R, Green D, Moore MA, Nachman RL, Rafii S: Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-668.
30. Kimura H, Ishibashi T, Uchida T, Maruyama Y, Friese P, Burstein SA: Interleukin 6 is a differentiation factor for human megakaryocytes in vitro. Eur J Immunol 1990; 20: 1927-1931.
31. Maitre B, Boussat S, Jean D, et al.: Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 2001; 18: 100-106.
32. Thickett DR, Armstrong L, Millar AB: A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002; 166: 1332-1337.
33. Thickett DR, Armstrong L, Christie SJ, Millar AB: Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164: 1601-1605.
34. Berse B, Hunt JA, Diegel RJ, et al.: Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999; 115: 176-182.
35. Choi SH, Park EY, Jung HL, et al.: Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion. J Korean Med Sci 2006; 21: 608-613.